| Dox@pVP-AuNPs | doxorubicin loaded povidone coated gold nanoparticles |
| 5FU | 5-fluorouracil |
| AAM | acrylamide |
| Ag-NPs | silver nanoparticles |
| Amph-pVP | amphiphilic poly-N-vinylpyrrolidone |
| Au-NPs | gold nanoparticles |
| AuPd@pVP NP | povidone coated gold-palladium nanoparticles |
| BTZ | bortezomib |
| CDDP | cis-diamminedichloroplatinum II |
| CTAB | cetyl trimethylammonium bromide |
| Cur | curcumin |
| DDSs | drug delivery systems |
| DEAEMA | 2-(diethylamino)ethyl methacrylate |
| FA–CurAu-PVP NPs | folate–curcumin-loaded gold–polyvinylpyrrolidone nanoparticles |
| Gd2O3 NPs | gadolin oxide nanoparticles |
| GEF | gefitnib |
| GO-NPs | graphene oxide nanoparticles |
| HPMC | hydroxypropyl methylcellulose |
| HPβCD | hydroxypropyl-β-cyclodextrin |
| LCST | lower critical solution temperature |
| NaBH4 | sodium borohydride |
| NAC | N-acetyl-l-cysteine |
| NC | nanocapsules |
| NE | nanoemulsion |
| NETs | neutrophil extracellular traps |
| NIPAAm/NVP | poly(N-isopropylacrylamide-co-N-vinylpyrrolidon |
| NVP | 1-vinyl-2-pyrrolidone |
| PEO | poly(ethylene oxide) |
| PEO-b-P2VP | 2-vinyl pyridine poly(ethylene oxide)-b-poly(2-vin(2-vinyl pyridine |
| PLGA-H | polylactide-co-glycolide |
| PLGA-PEG | polylactide-co-glycolide-co-polyethylenglycol |
| PTT | photothermal therapy |
| pVP | poly (N-vinyl pyrrolidone) |
| pVP-I | povidone iodine |
| pVP-Ag-NPs | povidone coated silver nanoparticles |
| QSR | quercetin |
| RAFT | the reversible addition–fragmentation chain-transfer polymerization |
| SAS | supercritical antisolvent process |
| THP-1 | human monocytic cell line |